Cargando…
Cork-in-bottle mechanism of inhibitor binding to mammalian complex I
Mitochondrial complex I (NADH:ubiquinone oxidoreductase), a major contributor of free energy for oxidative phosphorylation, is increasingly recognized as a promising drug target for ischemia-reperfusion injury, metabolic disorders, and various cancers. Several pharmacologically relevant but structur...
Autores principales: | Chung, Injae, Serreli, Riccardo, Cross, Jason B., Di Francesco, M. Emilia, Marszalek, Joseph R., Hirst, Judy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121435/ https://www.ncbi.nlm.nih.gov/pubmed/33990335 http://dx.doi.org/10.1126/sciadv.abg4000 |
Ejemplares similares
-
Structural Basis of Mammalian Respiratory Complex I Inhibition by Medicinal Biguanides
por: Bridges, Hannah R., et al.
Publicado: (2023) -
Making the leap from structure to mechanism: are the open states of mammalian complex I identified by cryoEM resting states or catalytic intermediates?
por: Chung, Injae, et al.
Publicado: (2022) -
Investigation of hydrated channels and proton pathways in a high-resolution cryo-EM structure of mammalian complex I
por: Grba, Daniel N., et al.
Publicado: (2023) -
The antipsychotic medications aripiprazole, brexpiprazole and cariprazine are off-target respiratory chain complex I inhibitors
por: Hardy, Rachel E., et al.
Publicado: (2023) -
Cork-in-Bottle Occlusion of Fluoride Ion Channels by Crystallization Chaperones
por: McIlwain, Benjamin C., et al.
Publicado: (2018)